# Scantox

> Preclinical contract research organization (CRO) founded in 1977. Supports pharmaceutical,
> biotech, agrochemical, and medical device companies from early discovery through
> IND-enabling development. Operations in Denmark (HQ), Sweden, Austria, and the UK
> (Manchester). Owned by Impilo. Serves clients in English, Japanese, and Korean.

Full site index: https://scantox.com/sitemap_index.xml
Detailed service and capability guide: https://scantox.com/llms-full.txt

---

## Business Units

- **CNS Discovery** — In vivo and in vitro services for neurodegenerative disease research, including transgenic and induced animal models, behavioral testing, and CNS biomarkers
- **Regulatory & Safety Toxicology** — GLP toxicology studies supporting IND, CTA, and NDA/MAA submissions; specialist expertise in Göttingen Minipig as a non-rodent species
- **Genetic Toxicology** — Full genotoxicity screening and GLP regulatory testing (Scantox Manchester, formerly Gentronix); includes DuplexSeq™ mutagenesis assays and Big Blue® TGR assay
- **Pharmaceutical Development & Analytical** — Small molecule preformulation, dose form development, and product analysis

---

## Key Pages

### Company
- [Home](https://scantox.com/): Overview of services and therapeutic focus
- [Locations](https://scantox.com/about-scantox/locations/): Sites in Denmark, Sweden, Austria, UK
- [Testimonials](https://scantox.com/resources/testimonials/)
- [Publications](https://scantox.com/resources/publications/)

### CNS Discovery
- [Discovery Services Overview](https://scantox.com/services/discovery/)
- [In Vivo Animal Models](https://scantox.com/services/discovery/animal-models/): Full transgenic and induced disease model portfolio
- [In Vitro Services](https://scantox.com/services/discovery/in-vitro-services/): Cell-based assays for neurodegeneration and neuroinflammation
- [Alzheimer's Disease Models](https://scantox.com/services/discovery/animal-models/alzheimers-disease-transgenic-mouse-models/)
- [Parkinson's Disease Models](https://scantox.com/services/discovery/animal-models/parkinsons-disease-transgenic-mouse-models/)
- [ALS Models](https://scantox.com/services/discovery/animal-models/amyotrophic-lateral-sclerosis-transgenic-mouse-models/)
- [Huntington's Disease Models](https://scantox.com/services/discovery/animal-models/huntingtons-disease-mouse-models/)
- [Lysosomal Storage Disease Models](https://scantox.com/services/discovery/animal-models/lysosomal-storage-diseases/)
- [Induced Disease Models](https://scantox.com/services/discovery/animal-models/induced-disease-models/)
- [Behavioral Testing](https://scantox.com/services/discovery/behavioral-tests/)

### Regulatory & Safety Toxicology
- [Regulatory Toxicology Overview](https://scantox.com/services/toxicology/)

### Genetic Toxicology
- [Genetic Toxicology Services Overview](https://scantox.com/services/genotox/)
- [Genetic Toxicology Testing (Screening)](https://scantox.com/services/genotox/genetic-toxicology-testing/)
- [GLP Genotoxicity Services](https://scantox.com/services/genotox/regulatory-genotoxicity-studies/)
- [DuplexSeq™ Mutagenesis Assays](https://scantox.com/services/genotox/genetic-toxicology-testing/duplexseq-mutagenesis-assays/): Error-corrected next-generation sequencing for genomic safety assessment
- [OECD 488 Big Blue® TGR Assay](https://scantox.com/services/genotox/regulatory-genotoxicity-studies/oecd-488-big-blue-in-vivo/)
- [OECD 471 Ames Test](https://scantox.com/services/genotox/regulatory-genotoxicity-studies/oecd-471-ames-test/)

### Pharmaceutical Development & Analytical
- [Pharmaceutical Development & Analytical Overview](https://scantox.com/services/analytical/)
- [Product Analysis](https://scantox.com/services/analytical/product-analysis/)
- [Dose Form Analysis](https://scantox.com/services/analytical/dose-form-analysis/)

### Resources
- [Webinars](https://scantox.com/news-events/newsletter/)
- [Newsletters](https://scantox.com/news-events/newsletter/)

---

## Contact

https://scantox.com/contact/